VENETOCLAX

VENETOCLAX was reported 62878 times

VENETOCLAX is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALLOGENIC STEM CELL TRANSPLANTATION 85 0.5380
1 ACUTE MYELOID LEUKAEMIA REFRACTORY 76 0.4419
2 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT 33 0.3708
3 PLATELET TRANSFUSION 401 0.3113
4 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 211 0.3027
5 T-CELL PROLYMPHOCYTIC LEUKAEMIA 28 0.3011
6 ACUTE MYELOID LEUKAEMIA RECURRENT 615 0.2862
7 BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA 23 0.2840
8 ASPIRATION BONE MARROW 36 0.2707
9 PROTOTHECOSIS 25 0.2660
10 MINIMAL RESIDUAL DISEASE 118 0.2443
11 CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY 21 0.2234
12 RED BLOOD CELL TRANSFUSION 87 0.2122
13 CORD BLOOD TRANSPLANT THERAPY 18 0.2118
14 CHRONIC LYMPHOCYTIC LEUKAEMIA 778 0.1638
15 CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION 32 0.1531
16 BONE MARROW TRANSPLANT 284 0.1496
17 MANTLE CELL LYMPHOMA 206 0.1353
18 TUMOUR LYSIS SYNDROME 1180 0.1340
19 MANTLE CELL LYMPHOMA RECURRENT 57 0.1310
20 BLAST CELL COUNT INCREASED 137 0.1307
21 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 29 0.1261
22 ACUTE MYELOID LEUKAEMIA 1935 0.1240
23 REFRACTORY CANCER 26 0.1215
24 HOSPICE CARE 1062 0.1074
25 CONGENITAL APLASIA 33 0.1061
26 BLAST CELLS PRESENT 48 0.0998
27 STEM CELL TRANSPLANT 249 0.0996
28 CYTOPENIA 1168 0.0953
29 INFUSION 39 0.0944
30 MYELOSUPPRESSION 3045 0.0845
31 TRANSFUSION 876 0.0835
32 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 52 0.0793
33 TRANSPLANT 185 0.0778
34 INVESTIGATION ABNORMAL 104 0.0723
35 GRANULOCYTE COUNT DECREASED 132 0.0711
36 LEUKAEMIA RECURRENT 113 0.0668
37 CHLOROMA 28 0.0664
38 ASPERGILLUS INFECTION 429 0.0653
39 DISEASE RISK FACTOR 26 0.0647
40 PNEUMONIA FUNGAL 249 0.0631
41 BLOOD URIC ACID ABNORMAL 25 0.0613
42 ANAL INFLAMMATION 39 0.0610
43 BACILLUS INFECTION 37 0.0585
44 CHEMOTHERAPY 217 0.0573
45 BIOPSY BONE MARROW 26 0.0556
46 BLOOD PRODUCT TRANSFUSION DEPENDENT 23 0.0546
47 SINUSITIS FUNGAL 41 0.0511
48 SARS-COV-2 TEST NEGATIVE 34 0.0504
49 PALLIATIVE CARE 76 0.0496
50 HYPERPHOSPHATAEMIA 106 0.0493
51 FEBRILE NEUTROPENIA 3178 0.0479
52 DIFFERENTIATION SYNDROME 35 0.0477
53 LEUKAEMIA 445 0.0471
54 BONE MARROW DISORDER 140 0.0463
55 PACKED RED BLOOD CELL TRANSFUSION 60 0.0453
56 HAEMOGLOBIN ABNORMAL 288 0.0447
57 LYMPHOCYTOSIS 94 0.0436
58 PLATELET DISORDER 110 0.0436
59 FUSARIUM INFECTION 30 0.0429
60 PERIORBITAL CELLULITIS 23 0.0428
61 WHITE BLOOD CELL COUNT ABNORMAL 272 0.0426
62 PSEUDOMONAL BACTERAEMIA 36 0.0422
63 SYSTEMIC MYCOSIS 48 0.0411
64 BIOPSY BONE MARROW ABNORMAL 18 0.0396
65 NEUTROPHIL COUNT ABNORMAL 109 0.0385
66 PLASMA CELL LEUKAEMIA 23 0.0383
67 MYELOPROLIFERATIVE NEOPLASM 25 0.0377
68 INTENSIVE CARE 53 0.0373
69 PULMONARY MUCORMYCOSIS 19 0.0360
70 PLATELET COUNT ABNORMAL 217 0.0359
71 CAMPYLOBACTER GASTROENTERITIS 21 0.0354
72 RED BLOOD CELL COUNT ABNORMAL 52 0.0354
73 TRANSFUSION REACTION 31 0.0353
74 AUTOIMMUNE HAEMOLYTIC ANAEMIA 121 0.0353
75 ABDOMINAL LYMPHADENOPATHY 30 0.0346
76 CENTRAL VENOUS CATHETERISATION 104 0.0344
77 ESCHERICHIA BACTERAEMIA 81 0.0344
78 SOFT TISSUE INFECTION 63 0.0344
79 LYMPHOCYTE COUNT ABNORMAL 38 0.0337
80 BLOOD PHOSPHORUS INCREASED 92 0.0337
81 NEUTROPENIC INFECTION 32 0.0334
82 FEBRILE INFECTION 39 0.0331
83 FUNGAL SEPSIS 27 0.0325
84 SYSTEMIC CANDIDA 80 0.0318
85 CEREBRAL ASPERGILLOSIS 19 0.0309
86 DYSPLASIA 37 0.0308
87 MEDICAL PROCEDURE 50 0.0300
88 LYMPHOCYTE COUNT INCREASED 97 0.0297
89 NEUTROPHIL COUNT DECREASED 1190 0.0292
90 FULL BLOOD COUNT DECREASED 582 0.0289
91 FULL BLOOD COUNT ABNORMAL 303 0.0286
92 STREPTOCOCCAL BACTERAEMIA 31 0.0285
93 HYPERURICAEMIA 117 0.0284
94 ENTEROCOCCAL BACTERAEMIA 30 0.0283
95 ESCHERICHIA SEPSIS 82 0.0283
96 BRONCHOPULMONARY ASPERGILLOSIS 219 0.0282
97 HYPERLEUKOCYTOSIS 25 0.0282
98 PSEUDOMONAL SEPSIS 49 0.0280
99 ADVERSE FOOD REACTION 26 0.0279
100 BACTERIAL SEPSIS 91 0.0279
101 BACTERAEMIA 331 0.0279
102 PLATELET COUNT DECREASED 2936 0.0275
103 CHRONIC MYELOMONOCYTIC LEUKAEMIA 18 0.0273
104 HAEMATOTOXICITY 255 0.0268
105 NEUTROPENIA 3635 0.0267
106 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 25 0.0264
107 PARAINFLUENZAE VIRUS INFECTION 40 0.0263
108 KLEBSIELLA SEPSIS 29 0.0257
109 BLOOD URIC ACID INCREASED 146 0.0253
110 RHINOVIRUS INFECTION 98 0.0252
111 STENOTROPHOMONAS INFECTION 34 0.0251
112 NEUTROPENIC SEPSIS 177 0.0248
113 DIFFUSE LARGE B-CELL LYMPHOMA 187 0.0242
114 PLASMA CELL MYELOMA REFRACTORY 32 0.0239
115 FOLLICULAR LYMPHOMA 21 0.0239
116 MYELODYSPLASTIC SYNDROME 345 0.0238
117 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 22 0.0238
118 HAEMATOLOGICAL INFECTION 58 0.0237
119 COVID-19 PNEUMONIA 277 0.0234
120 PANCYTOPENIA 1300 0.0232
121 APLASIA 45 0.0230
122 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 19 0.0225
123 IMMUNODEFICIENCY 336 0.0225
124 FEBRILE BONE MARROW APLASIA 95 0.0223
125 WHITE BLOOD CELL COUNT DECREASED 2384 0.0220
126 MUCORMYCOSIS 57 0.0219
127 HYPOGAMMAGLOBULINAEMIA 144 0.0219
128 DISCOURAGEMENT 51 0.0218
129 SPLENIC INFARCTION 38 0.0218
130 SPLENOMEGALY 251 0.0214
131 RED BLOOD CELL COUNT DECREASED 600 0.0210
132 PULMONARY SEPSIS 30 0.0206
133 BLOOD DISORDER 164 0.0204
134 THROMBOCYTOPENIA 2281 0.0204
135 NEUTROPENIC COLITIS 42 0.0203
136 PNEUMONIA INFLUENZAL 24 0.0202
137 BLOOD COUNT ABNORMAL 305 0.0201
138 REHABILITATION THERAPY 77 0.0199
139 STAPHYLOCOCCAL BACTERAEMIA 85 0.0195
140 DEVICE RELATED SEPSIS 39 0.0194
141 VASCULAR DEVICE INFECTION 87 0.0192
142 CLOSTRIDIUM COLITIS 23 0.0189
143 WHITE BLOOD CELL DISORDER 50 0.0187
144 GRAFT VERSUS HOST DISEASE IN SKIN 41 0.0186
145 VENA CAVA THROMBOSIS 30 0.0180
146 ACUTE LEUKAEMIA 29 0.0179
147 LYMPHADENOPATHY 634 0.0179
148 STREPTOCOCCAL SEPSIS 21 0.0177
149 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 23 0.0175
150 HEPATOSPLENOMEGALY 44 0.0171
151 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 36 0.0169
152 PNEUMONIA KLEBSIELLA 31 0.0168
153 IMMUNOGLOBULINS DECREASED 23 0.0167
154 MEDICAL DEVICE IMPLANTATION 26 0.0166
155 HAEMOGLOBIN DECREASED 1651 0.0161
156 FUNGAEMIA 25 0.0159
157 RECURRENT CANCER 64 0.0157
158 BLOOD LACTATE DEHYDROGENASE INCREASED 247 0.0156
159 BRAIN ABSCESS 39 0.0154
160 BLOOD TEST ABNORMAL 215 0.0153
161 SQUAMOUS CELL CARCINOMA OF SKIN 91 0.0151
162 LYMPHOMA 232 0.0150
163 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 34 0.0146
164 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 32 0.0145
165 ESSENTIAL HYPERTENSION 26 0.0142
166 GENE MUTATION 28 0.0141
167 GRANULOCYTOPENIA 80 0.0140
168 ATYPICAL PNEUMONIA 42 0.0140
169 LYMPH NODE PAIN 26 0.0140
170 INFECTION 2017 0.0139
171 ENDOTRACHEAL INTUBATION 39 0.0139
172 ESCHERICHIA INFECTION 114 0.0138
173 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 38 0.0137
174 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 103 0.0137
175 AGRANULOCYTOSIS 255 0.0137
176 PNEUMONIA PSEUDOMONAL 21 0.0137
177 BONE MARROW FAILURE 276 0.0136
178 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 19 0.0134
179 BLOOD IMMUNOGLOBULIN G DECREASED 33 0.0133
180 ACUTE GRAFT VERSUS HOST DISEASE 60 0.0131
181 SQUAMOUS CELL CARCINOMA 123 0.0131
182 DISEASE PROGRESSION 1527 0.0129
183 PNEUMONIA BACTERIAL 118 0.0128
184 FLUID INTAKE REDUCED 64 0.0128
185 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 33 0.0128
186 OSTEOLYSIS 26 0.0127
187 FIBROSIS 39 0.0127
188 LABORATORY TEST ABNORMAL 369 0.0125
189 CYTOMEGALOVIRUS INFECTION REACTIVATION 55 0.0124
190 OPPORTUNISTIC INFECTION 23 0.0124
191 ORAL FUNGAL INFECTION 34 0.0124
192 BLOOD POTASSIUM ABNORMAL 33 0.0124
193 ATRIAL FIBRILLATION 1198 0.0123
194 PROCTALGIA 78 0.0121
195 SEPSIS 1352 0.0121
196 DEATH 10347 0.0120
197 ACUTE LYMPHOCYTIC LEUKAEMIA 34 0.0120
198 BODY TEMPERATURE ABNORMAL 22 0.0119
199 SEPTIC SHOCK 519 0.0119
200 PSEUDOMONAS INFECTION 102 0.0119
201 CATHETER PLACEMENT 22 0.0119
202 GRAFT VERSUS HOST DISEASE 85 0.0118
203 SPLEEN DISORDER 20 0.0118
204 STAPHYLOCOCCAL SEPSIS 58 0.0117
205 KLEBSIELLA INFECTION 59 0.0117
206 ABDOMINAL MASS 31 0.0116
207 LYMPHOCYTE COUNT DECREASED 203 0.0115
208 SYSTEMIC INFECTION 19 0.0115
209 SKIN INFECTION 128 0.0114
210 CLOSTRIDIUM DIFFICILE COLITIS 120 0.0113
211 LUNG CONSOLIDATION 31 0.0111
212 BLOOD CREATININE ABNORMAL 38 0.0110
213 INFECTION SUSCEPTIBILITY INCREASED 24 0.0110
214 ANAEMIA 2090 0.0109
215 WHITE BLOOD CELL COUNT INCREASED 419 0.0109
216 B-CELL LYMPHOMA 37 0.0109
217 OESOPHAGEAL CANDIDIASIS 43 0.0108
218 PLASMA CELL MYELOMA RECURRENT 35 0.0108
219 ENTEROCOCCAL INFECTION 52 0.0108
220 BACTERIAL INFECTION 199 0.0107
221 LUNG OPACITY 28 0.0106
222 HYPERBILIRUBINAEMIA 110 0.0106
223 NEOPLASM 122 0.0106
224 PNEUMOCYSTIS JIROVECII PNEUMONIA 106 0.0105
225 APLASIA PURE RED CELL 35 0.0102
226 CYTOMEGALOVIRUS COLITIS 23 0.0100
227 NEOPLASM RECURRENCE 33 0.0097
228 INTENTIONAL PRODUCT USE ISSUE 852 0.0097
229 MULTIPLE ORGAN DYSFUNCTION SYNDROME 275 0.0097
230 CAPILLARY LEAK SYNDROME 20 0.0097
231 ADENOVIRUS INFECTION 28 0.0096
232 BK VIRUS INFECTION 32 0.0095
233 COVID-19 1663 0.0095
234 RENAL FUNCTION TEST ABNORMAL 44 0.0095
235 CYTOKINE RELEASE SYNDROME 190 0.0095
236 PNEUMONIA VIRAL 30 0.0094
237 IMMUNE THROMBOCYTOPENIA 43 0.0094
238 HERPES SIMPLEX 60 0.0092
239 CYTOMEGALOVIRUS CHORIORETINITIS 18 0.0092
240 SUBDURAL HAEMATOMA 132 0.0092
241 APLASTIC ANAEMIA 48 0.0092
242 HAEMOLYTIC ANAEMIA 82 0.0091
243 CELL DEATH 18 0.0091
244 PLASMA CELL MYELOMA 353 0.0090
245 METASTATIC NEOPLASM 39 0.0090
246 HOSPITALISATION 1382 0.0090
247 HYPOPHOSPHATAEMIA 66 0.0089
248 BLOOD MAGNESIUM DECREASED 77 0.0089
249 ANAL ABSCESS 48 0.0089
250 NON-CARDIAC CHEST PAIN 28 0.0088
251 BASAL CELL CARCINOMA 138 0.0088
252 DISSEMINATED INTRAVASCULAR COAGULATION 124 0.0088
253 HAEMOLYSIS 68 0.0088
254 CLOSTRIDIUM DIFFICILE INFECTION 190 0.0087
255 LYMPHADENITIS 21 0.0087
256 LEUKOCYTOSIS 156 0.0086
257 MYELOFIBROSIS 26 0.0086
258 HYPERCALCAEMIA 106 0.0086
259 HYPOCALCAEMIA 162 0.0086
260 LUNG INFILTRATION 75 0.0085
261 HYPOALBUMINAEMIA 66 0.0085
262 SARS-COV-2 TEST POSITIVE 112 0.0085
263 PNEUMONIA 2733 0.0084
264 SKIN CANCER 181 0.0084
265 PHLEBITIS 43 0.0084
266 METASTASES TO MENINGES 19 0.0083
267 CHOLECYSTITIS INFECTIVE 23 0.0083
268 RESPIRATORY SYNCYTIAL VIRUS INFECTION 72 0.0083
269 PYREXIA 2849 0.0082
270 PROTEIN TOTAL DECREASED 31 0.0082
271 PROSTATITIS 25 0.0082
272 HEPATITIS B REACTIVATION 26 0.0082
273 CLOSTRIDIUM TEST POSITIVE 18 0.0082
274 HERPES VIRUS INFECTION 47 0.0082
275 ATRIAL FLUTTER 65 0.0081
276 NECK MASS 23 0.0081
277 HEPATIC CYTOLYSIS 103 0.0081
278 OFF LABEL USE 7028 0.0080
279 URINARY TRACT OBSTRUCTION 19 0.0080
280 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 66 0.0080
281 ESCHERICHIA URINARY TRACT INFECTION 34 0.0080
282 VENOOCCLUSIVE DISEASE 20 0.0080
283 HYPOPHAGIA 203 0.0079
284 CATHETER SITE INFECTION 30 0.0079
285 BLOOD POTASSIUM INCREASED 127 0.0078
286 GASTROINTESTINAL INFECTION 70 0.0078
287 ENDOCARDITIS 40 0.0078
288 CARDIAC DYSFUNCTION 29 0.0078
289 ERYSIPELAS 39 0.0078
290 LEUKOPENIA 386 0.0077
291 CORONAVIRUS INFECTION 51 0.0077
292 ORAL INFECTION 30 0.0077
293 APPENDICITIS 71 0.0076
294 THERAPY PARTIAL RESPONDER 118 0.0076
295 BENIGN PROSTATIC HYPERPLASIA 39 0.0075
296 MONOCYTE COUNT INCREASED 27 0.0074
297 BLOOD CALCIUM INCREASED 65 0.0074
298 RESPIRATORY TRACT INFECTION 188 0.0072
299 CYSTITIS HAEMORRHAGIC 29 0.0072
300 PULMONARY ALVEOLAR HAEMORRHAGE 40 0.0071
301 FUNGAL INFECTION 237 0.0071
302 HAEMORRHAGE URINARY TRACT 18 0.0071
303 OXYGEN SATURATION ABNORMAL 20 0.0070
304 DECREASED ACTIVITY 76 0.0070
305 BLOOD BLISTER 22 0.0070
306 PETECHIAE 73 0.0070
307 CHRONIC GRAFT VERSUS HOST DISEASE 25 0.0069
308 PRODUCT USE COMPLAINT 109 0.0069
309 LOCALISED INFECTION 167 0.0069
310 RED BLOOD CELL COUNT INCREASED 19 0.0069
311 PLEURAL EFFUSION 419 0.0069
312 DYSCHEZIA 21 0.0069
313 PROSTATOMEGALY 27 0.0069
314 CELLULITIS 346 0.0069
315 IMMUNOSUPPRESSION 60 0.0068
316 HAEMORRHOIDS 132 0.0068
317 CYTOMEGALOVIRUS VIRAEMIA 30 0.0067
318 MOUTH HAEMORRHAGE 49 0.0067
319 DIVERTICULITIS 185 0.0067
320 PYODERMA GANGRENOSUM 24 0.0067
321 GASTROINTESTINAL TOXICITY 32 0.0067
322 INFLAMMATORY MARKER INCREASED 33 0.0067
323 STREPTOCOCCAL INFECTION 37 0.0066
324 HAEMORRHAGE INTRACRANIAL 99 0.0066
325 HAEMATOCRIT DECREASED 131 0.0066
326 ACUTE RESPIRATORY FAILURE 127 0.0066
327 LYMPHOPENIA 93 0.0066
328 ONYCHOCLASIS 45 0.0065
329 IMMUNE SYSTEM DISORDER 86 0.0065
330 TONGUE ULCERATION 22 0.0065
331 LIVER ABSCESS 21 0.0065
332 FUNGAL SKIN INFECTION 26 0.0064
333 ENTEROCOLITIS 37 0.0064
334 BONE LESION 23 0.0064
335 IMMUNE THROMBOCYTOPENIC PURPURA 18 0.0064
336 CHOLECYSTITIS ACUTE 36 0.0063
337 LUNG ADENOCARCINOMA 19 0.0063
338 CARDIAC TAMPONADE 30 0.0063
339 BLOOD PHOSPHORUS DECREASED 23 0.0063
340 HYPOKALAEMIA 290 0.0063
341 GASTRIC INFECTION 24 0.0063
342 HYPERVOLAEMIA 31 0.0063
343 INGUINAL HERNIA 38 0.0062
344 CLOSTRIDIAL INFECTION 21 0.0062
345 INCREASED TENDENCY TO BRUISE 57 0.0062
346 UNEVALUABLE EVENT 465 0.0061
347 GOUT 110 0.0061
348 NEOPLASM MALIGNANT 406 0.0061
349 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 36 0.0061
350 PLATELET COUNT INCREASED 79 0.0061
351 NON-SMALL CELL LUNG CANCER 29 0.0060
352 DERMATITIS EXFOLIATIVE GENERALISED 21 0.0060
353 CARDIAC FAILURE ACUTE 40 0.0060
354 ECCHYMOSIS 41 0.0060
355 SUPRAVENTRICULAR TACHYCARDIA 57 0.0059
356 DEVICE RELATED INFECTION 91 0.0059
357 HAEMORRHAGIC DIATHESIS 21 0.0059
358 HAEMORRHAGE 616 0.0059
359 ABSCESS LIMB 25 0.0059
360 CANDIDA INFECTION 99 0.0059
361 BLOOD BILIRUBIN INCREASED 158 0.0058
362 CHRONIC MYELOID LEUKAEMIA 27 0.0058
363 RESPIRATORY FAILURE 425 0.0058
364 HYPOMAGNESAEMIA 81 0.0058
365 HEPATIC ENZYME ABNORMAL 29 0.0058
366 ATELECTASIS 56 0.0058
367 PULMONARY MASS 86 0.0058
368 CEREBRAL HAEMORRHAGE 205 0.0057
369 CARDIOTOXICITY 51 0.0057
370 BLOOD POTASSIUM DECREASED 171 0.0057
371 NECROTISING FASCIITIS 20 0.0057
372 ORGANISING PNEUMONIA 28 0.0056
373 TONSILLITIS 29 0.0056
374 PULMONARY OEDEMA 248 0.0055
375 BONE CANCER 24 0.0055
376 THROMBOCYTOSIS 20 0.0055
377 EPSTEIN-BARR VIRUS INFECTION 34 0.0054
378 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 386 0.0054
379 HEART RATE ABNORMAL 30 0.0054
380 CARDIAC PACEMAKER INSERTION 32 0.0054
381 LUNG INFECTION 83 0.0053
382 HYPERKALAEMIA 186 0.0053
383 VENOOCCLUSIVE LIVER DISEASE 26 0.0053
384 BODY TEMPERATURE INCREASED 107 0.0052
385 PARONYCHIA 23 0.0052
386 TASTE DISORDER 106 0.0052
387 SUBCUTANEOUS ABSCESS 25 0.0052
388 MALNUTRITION 58 0.0052
389 ACUTE PULMONARY OEDEMA 29 0.0052
390 FACIAL PARALYSIS 44 0.0052
391 HEPATITIS B 31 0.0051
392 C-REACTIVE PROTEIN INCREASED 184 0.0051
393 HYPOXIA 178 0.0050
394 BLOOD SODIUM DECREASED 95 0.0050
395 DISEASE COMPLICATION 23 0.0050
396 COLITIS 190 0.0050
397 MUCOSAL INFLAMMATION 131 0.0050
398 PULMONARY HAEMORRHAGE 39 0.0050
399 DRUG RESISTANCE 128 0.0050
400 GINGIVAL BLEEDING 68 0.0050
401 ABDOMINAL ABSCESS 22 0.0050
402 GALLBLADDER OPERATION 20 0.0049
403 FOOD INTOLERANCE 18 0.0049
404 ELECTROLYTE IMBALANCE 57 0.0049
405 DEAFNESS UNILATERAL 27 0.0049
406 STAPHYLOCOCCAL INFECTION 161 0.0049
407 SKIN LACERATION 53 0.0049
408 ARTHRITIS BACTERIAL 20 0.0049
409 PULMONARY THROMBOSIS 53 0.0049
410 SPINAL STENOSIS 20 0.0048
411 ASTHENIA 1816 0.0048
412 PNEUMONITIS 131 0.0048
413 BLOOD CALCIUM DECREASED 54 0.0048
414 PERICARDIAL EFFUSION 111 0.0048
415 CHOLECYSTITIS 57 0.0048
416 TERMINAL STATE 32 0.0048
417 EYE OPERATION 22 0.0048
418 ACCIDENT 57 0.0048
419 UROSEPSIS 44 0.0048
420 GENERAL PHYSICAL HEALTH DETERIORATION 550 0.0047
421 LARGE INTESTINE PERFORATION 33 0.0047
422 VIRAL INFECTION 158 0.0047
423 ORGAN FAILURE 19 0.0047
424 NIGHT SWEATS 151 0.0047
425 GINGIVITIS 25 0.0046
426 STOMATITIS 281 0.0046
427 MALIGNANT MELANOMA 62 0.0046
428 LYMPHOEDEMA 32 0.0046
429 LUNG DISORDER 224 0.0046
430 SERUM FERRITIN INCREASED 24 0.0045
431 SURGERY 266 0.0045
432 MENINGITIS 30 0.0045
433 BREATH SOUNDS ABNORMAL 22 0.0045
434 GENERAL PHYSICAL CONDITION ABNORMAL 30 0.0044
435 VEIN DISORDER 22 0.0044
436 HEPATIC LESION 19 0.0044
437 POISONING 55 0.0044
438 TOOTH INFECTION 57 0.0043
439 TOOTH ABSCESS 44 0.0043
440 ARTHRITIS INFECTIVE 20 0.0043
441 NEUTROPHIL COUNT INCREASED 44 0.0043
442 CHOLECYSTECTOMY 49 0.0043
443 UPPER RESPIRATORY TRACT INFECTION 197 0.0043
444 FAECES SOFT 31 0.0043
445 SPINAL COMPRESSION FRACTURE 35 0.0042
446 ENTERITIS 27 0.0042
447 RHINITIS 34 0.0042
448 LIMB OPERATION 20 0.0042
449 HIP FRACTURE 134 0.0042
450 EMBOLISM 34 0.0041
451 STENT PLACEMENT 33 0.0041
452 CONSTIPATION 883 0.0040
453 FAILURE TO THRIVE 21 0.0040
454 HYPERTRANSAMINASAEMIA 28 0.0040
455 EPISTAXIS 300 0.0040
456 RESPIRATORY DISORDER 119 0.0040
457 CYTOMEGALOVIRUS INFECTION 66 0.0040
458 THERAPY NON-RESPONDER 178 0.0040
459 HAEMOGLOBIN INCREASED 18 0.0039
460 CORONARY ARTERIAL STENT INSERTION 20 0.0039
461 TROPONIN INCREASED 30 0.0039
462 APPETITE DISORDER 26 0.0039
463 ENCEPHALITIS 27 0.0039
464 SKIN MASS 26 0.0039
465 CARDIAC FAILURE 310 0.0039
466 HAEMATOMA 100 0.0039
467 BLOOD CREATININE INCREASED 252 0.0039
468 INTERNAL HAEMORRHAGE 44 0.0038
469 PATHOGEN RESISTANCE 35 0.0038
470 SKIN LESION 105 0.0038
471 CHILLS 447 0.0038
472 PROSTATIC DISORDER 21 0.0038
473 HYPERTHERMIA 29 0.0038
474 MUSCULOSKELETAL DISORDER 72 0.0038
475 RENAL DISORDER 176 0.0038
476 DIARRHOEA 2438 0.0038
477 HERNIA 73 0.0038
478 DECREASED APPETITE 873 0.0038
479 SMALL INTESTINAL OBSTRUCTION 46 0.0037
480 FOOD POISONING 20 0.0037
481 COMPRESSION FRACTURE 20 0.0037
482 SUBARACHNOID HAEMORRHAGE 38 0.0037
483 TOOTH EXTRACTION 46 0.0037
484 INFLUENZA 410 0.0037
485 POLYNEUROPATHY 44 0.0037
486 BLOOD PRESSURE ABNORMAL 73 0.0037
487 MALIGNANT NEOPLASM PROGRESSION 376 0.0037
488 ABSCESS 58 0.0036
489 DEAFNESS 95 0.0036
490 GAIT INABILITY 121 0.0036
491 URINARY TRACT INFECTION 615 0.0036
492 EJECTION FRACTION DECREASED 56 0.0036
493 ACUTE KIDNEY INJURY 551 0.0036
494 HEPATOTOXICITY 80 0.0036
495 RESPIRATORY DISTRESS 98 0.0035
496 MELAENA 78 0.0035
497 ANAL FISSURE 19 0.0035
498 ASCITES 104 0.0035
499 DIALYSIS 50 0.0035
500 PERICARDITIS 59 0.0035
501 FATIGUE 2723 0.0035
502 SUDDEN DEATH 37 0.0035
503 CARDIAC OPERATION 30 0.0035
504 THROMBOTIC MICROANGIOPATHY 34 0.0035
505 BONE PAIN 204 0.0035
506 BLOOD URINE PRESENT 66 0.0035
507 ILLNESS 358 0.0035
508 LARGE INTESTINE POLYP 24 0.0035
509 MOUTH ULCERATION 73 0.0035
510 ILEUS 43 0.0035
511 BLOOD IRON DECREASED 41 0.0035
512 MASS 48 0.0034
513 BRONCHIECTASIS 23 0.0034
514 NEOPLASM PROGRESSION 118 0.0034
515 ARRHYTHMIA 160 0.0034
516 WOUND INFECTION 37 0.0034
517 SECOND PRIMARY MALIGNANCY 28 0.0034
518 DEHYDRATION 448 0.0034
519 POST PROCEDURAL INFECTION 27 0.0033
520 BRAIN FOG 52 0.0033
521 TORSADE DE POINTES 26 0.0033
522 DECUBITUS ULCER 27 0.0033
523 RENAL FAILURE 439 0.0033
524 PHARYNGITIS 41 0.0033
525 NOCTURIA 40 0.0033
526 PURPURA 29 0.0033
527 RALES 19 0.0033
528 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 157 0.0033
529 ORAL CANDIDIASIS 43 0.0033
530 HIP ARTHROPLASTY 50 0.0033
531 FLUID RETENTION 166 0.0033
532 ADVERSE DRUG REACTION 293 0.0033
533 CATARACT 194 0.0033
534 FEEDING DISORDER 66 0.0033
535 PERIPHERAL SENSORY NEUROPATHY 19 0.0032
536 ARTHROPOD BITE 24 0.0032
537 ORTHOSTATIC HYPOTENSION 56 0.0032
538 OXYGEN SATURATION DECREASED 180 0.0032
539 HERPES ZOSTER 184 0.0032
540 GASTROINTESTINAL DISORDER 286 0.0032
541 HEPATOMEGALY 31 0.0032
542 NODULE 41 0.0031
543 PRODUCT DISPENSING ERROR 68 0.0031
544 NEPHROPATHY TOXIC 35 0.0031
545 PNEUMOTHORAX 49 0.0031
546 DYSPHAGIA 292 0.0031
547 GROIN PAIN 27 0.0031
548 HEAD INJURY 97 0.0031
549 URINARY RETENTION 102 0.0031
550 CARDIAC DISORDER 286 0.0031
551 ABNORMAL FAECES 25 0.0030
552 VENTRICULAR TACHYCARDIA 50 0.0030
553 AORTIC ANEURYSM 23 0.0030
554 RENAL CYST 24 0.0030
555 ARTERIOSCLEROSIS CORONARY ARTERY 20 0.0030
556 ACUTE CORONARY SYNDROME 25 0.0030
557 DYSURIA 111 0.0030
558 SPINAL OPERATION 37 0.0030
559 NEUROPATHY PERIPHERAL 285 0.0030
560 HYPOTENSION 601 0.0030
561 LIVER FUNCTION TEST INCREASED 64 0.0030
562 HYPOACUSIS 128 0.0030
563 ORAL PAIN 66 0.0029
564 BRAIN NEOPLASM 27 0.0029
565 HYDRONEPHROSIS 22 0.0029
566 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 28 0.0029
567 EYE HAEMORRHAGE 39 0.0029
568 DISEASE RECURRENCE 139 0.0029
569 ASPIRATION 32 0.0029
570 SYNCOPE 292 0.0029
571 CHOLANGITIS 18 0.0029
572 CONTUSION 279 0.0029
573 FALL 964 0.0029
574 RESPIRATORY TRACT CONGESTION 46 0.0029
575 THROMBOSIS 232 0.0029
576 TRANSAMINASES INCREASED 64 0.0029
577 CHOLESTASIS 55 0.0029
578 THERAPEUTIC PRODUCT EFFECT DECREASED 128 0.0029
579 FRUSTRATION TOLERANCE DECREASED 23 0.0028
580 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 29 0.0028
581 MYOCARDIAL ISCHAEMIA 32 0.0028
582 GASTROENTERITIS 41 0.0028
583 GENERAL SYMPTOM 21 0.0028
584 BRONCHITIS 207 0.0028
585 SPINAL FRACTURE 56 0.0028
586 RASH MACULO-PAPULAR 62 0.0028
587 HEPATIC FAILURE 84 0.0028
588 ANAL INCONTINENCE 25 0.0028
589 DRUG ERUPTION 49 0.0028
590 NAUSEA 2182 0.0028
591 LOSS OF CONSCIOUSNESS 353 0.0028
592 OEDEMA PERIPHERAL 335 0.0027
593 BLOOD UREA INCREASED 46 0.0027
594 PERIPHERAL SWELLING 423 0.0027
595 HAEMATURIA 94 0.0027
596 KNEE OPERATION 27 0.0027
597 RIB FRACTURE 56 0.0027
598 HYPONATRAEMIA 153 0.0027
599 APHTHOUS ULCER 21 0.0027
600 CARDIOMYOPATHY 40 0.0027
601 CORONARY ARTERY OCCLUSION 37 0.0027
602 PELVIC FRACTURE 21 0.0027
603 VENTRICULAR EXTRASYSTOLES 28 0.0027
604 POOR QUALITY SLEEP 58 0.0027
605 HAEMORRHAGIC STROKE 21 0.0027
606 COLON CANCER 40 0.0027
607 HICCUPS 22 0.0027
608 HEPATIC FUNCTION ABNORMAL 100 0.0027
609 CARDIO-RESPIRATORY ARREST 112 0.0027
610 DRUG INTERACTION 423 0.0027
611 GENERALISED OEDEMA 33 0.0027
612 CYST 33 0.0027
613 ACUTE RESPIRATORY DISTRESS SYNDROME 47 0.0027
614 HYPERSOMNIA 76 0.0026
615 TACHYPNOEA 36 0.0026
616 CYSTITIS 84 0.0026
617 WEIGHT DECREASED 729 0.0026
618 DRUG INTOLERANCE 251 0.0026
619 LOWER GASTROINTESTINAL HAEMORRHAGE 19 0.0026
620 EYE INFECTION 29 0.0026
621 NERVOUS SYSTEM DISORDER 80 0.0026
622 MOBILITY DECREASED 184 0.0026
623 SKIN ULCER 66 0.0026
624 ELECTROCARDIOGRAM ABNORMAL 20 0.0025
625 RENAL IMPAIRMENT 214 0.0025
626 CARDIAC ARREST 210 0.0025
627 PALLOR 69 0.0025
628 BLOOD ALBUMIN DECREASED 20 0.0025
629 MACULAR DEGENERATION 30 0.0025
630 NEUROTOXICITY 44 0.0025
631 POST PROCEDURAL COMPLICATION 48 0.0025
632 HAEMODYNAMIC INSTABILITY 19 0.0025
633 POST PROCEDURAL HAEMORRHAGE 29 0.0025
634 VASCULITIS 29 0.0025
635 BACK PAIN 578 0.0025
636 ACIDOSIS 19 0.0025
637 BLINDNESS UNILATERAL 35 0.0025
638 MUSCLE ATROPHY 31 0.0024
639 MYOCARDITIS 28 0.0024
640 NEPHROLITHIASIS 112 0.0024
641 OEDEMA 132 0.0024
642 EMOTIONAL DISORDER 75 0.0024
643 SPINAL DISORDER 23 0.0024
644 CHOLELITHIASIS 79 0.0024
645 COUGH 674 0.0024
646 URINE OUTPUT DECREASED 21 0.0024
647 HAEMOPTYSIS 67 0.0024
648 SINUS TACHYCARDIA 34 0.0024
649 ASPARTATE AMINOTRANSFERASE INCREASED 127 0.0024
650 MUSCULOSKELETAL CHEST PAIN 37 0.0024
651 GASTROINTESTINAL HAEMORRHAGE 199 0.0024
652 GASTRITIS 62 0.0024
653 ALTERED STATE OF CONSCIOUSNESS 51 0.0024
654 PRODUCTIVE COUGH 112 0.0023
655 SKIN DISORDER 78 0.0023
656 SHOCK HAEMORRHAGIC 19 0.0023
657 ATRIOVENTRICULAR BLOCK 18 0.0023
658 FLATULENCE 132 0.0023
659 WOUND 65 0.0023
660 LIVER DISORDER 103 0.0023
661 TOOTHACHE 42 0.0023
662 LIMB INJURY 63 0.0023
663 CHROMATURIA 52 0.0023
664 ALANINE AMINOTRANSFERASE INCREASED 141 0.0023
665 BRAIN INJURY 23 0.0023
666 CEREBRAL INFARCTION 56 0.0023
667 HEMIPLEGIA 19 0.0023
668 PNEUMONIA ASPIRATION 57 0.0023
669 COAGULOPATHY 38 0.0023
670 NERVE COMPRESSION 21 0.0023
671 DIZZINESS POSTURAL 22 0.0023
672 DRUG-INDUCED LIVER INJURY 71 0.0023
673 SEASONAL ALLERGY 32 0.0023
674 GASTRIC HAEMORRHAGE 26 0.0023
675 HYPERLIPIDAEMIA 27 0.0023
676 INTESTINAL OBSTRUCTION 85 0.0023
677 INFUSION RELATED REACTION 149 0.0022
678 HYPERTENSIVE CRISIS 25 0.0022
679 ISCHAEMIC STROKE 40 0.0022
680 GALLBLADDER DISORDER 40 0.0022
681 TOXIC EPIDERMAL NECROLYSIS 34 0.0022
682 SINUSITIS 229 0.0022
683 SKIN HAEMORRHAGE 33 0.0022
684 HEPATIC ENZYME INCREASED 151 0.0022
685 KIDNEY INFECTION 43 0.0022
686 VOMITING 1030 0.0022
687 CONFUSIONAL STATE 354 0.0022
688 ELECTROCARDIOGRAM QT PROLONGED 78 0.0022
689 PRODUCT USE ISSUE 407 0.0022
690 GASTRIC DISORDER 74 0.0022
691 LOWER RESPIRATORY TRACT INFECTION 98 0.0022
692 INFLAMMATION 111 0.0021
693 ACUTE MYOCARDIAL INFARCTION 63 0.0021
694 POLLAKIURIA 89 0.0021
695 SCIATICA 34 0.0021
696 DELIRIUM 74 0.0021
697 TEMPERATURE INTOLERANCE 22 0.0021
698 PRODUCT USE IN UNAPPROVED INDICATION 528 0.0021
699 HAEMATEMESIS 54 0.0021
700 HEART RATE IRREGULAR 48 0.0021
701 JAUNDICE 57 0.0021
702 DYSPEPSIA 207 0.0021
703 FOLLICULITIS 22 0.0021
704 DYSPNOEA EXERTIONAL 79 0.0021
705 KNEE ARTHROPLASTY 44 0.0021
706 DENTAL CARIES 23 0.0021
707 SINUS CONGESTION 28 0.0021
708 RETINAL DETACHMENT 19 0.0021
709 ANGINA PECTORIS 59 0.0021
710 SLUGGISHNESS 21 0.0021
711 PRODUCT PRESCRIBING ERROR 49 0.0021
712 DEEP VEIN THROMBOSIS 133 0.0020
713 PULMONARY EMBOLISM 194 0.0020
714 ABDOMINAL DISCOMFORT 341 0.0020
715 FLANK PAIN 19 0.0020
716 UPPER GASTROINTESTINAL HAEMORRHAGE 34 0.0020
717 ABDOMINAL PAIN 470 0.0020
718 RETCHING 43 0.0020
719 TACHYCARDIA 179 0.0020
720 BLADDER DISORDER 20 0.0020
721 DERMATITIS 42 0.0020
722 SPUTUM DISCOLOURED 19 0.0020
723 ABDOMINAL DISTENSION 209 0.0020
724 CEREBROVASCULAR ACCIDENT 339 0.0020
725 CONJUNCTIVITIS 37 0.0020
726 OSTEOMYELITIS 36 0.0020
727 HEPATIC STEATOSIS 37 0.0020
728 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 109 0.0020
729 FAECES DISCOLOURED 43 0.0020
730 HYPERTENSION 419 0.0020
731 NEURALGIA 48 0.0020
732 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 103 0.0020
733 PULMONARY CONGESTION 26 0.0020
734 SINUS DISORDER 39 0.0020
735 BACK DISORDER 32 0.0020
736 BODY HEIGHT DECREASED 21 0.0020
737 ADVERSE REACTION 26 0.0020
738 OROPHARYNGEAL PAIN 181 0.0020
739 CARDIAC FAILURE CONGESTIVE 157 0.0020
740 GASTROOESOPHAGEAL REFLUX DISEASE 157 0.0019
741 RHINORRHOEA 126 0.0019
742 EAR DISCOMFORT 20 0.0019
743 MALAISE 848 0.0019
744 DYSPNOEA 1092 0.0019
745 HEPATIC CIRRHOSIS 36 0.0019
746 MENTAL STATUS CHANGES 53 0.0019
747 FEELING COLD 53 0.0019
748 HYPERGLYCAEMIA 69 0.0019
749 PERIPHERAL COLDNESS 26 0.0019
750 CENTRAL NERVOUS SYSTEM LESION 26 0.0019
751 VENTRICULAR FIBRILLATION 21 0.0019
752 EAR INFECTION 50 0.0019
753 TRANSIENT ISCHAEMIC ATTACK 63 0.0019
754 ERUCTATION 36 0.0019
755 FLUID OVERLOAD 27 0.0019
756 CORONARY ARTERY DISEASE 56 0.0018
757 ORAL HERPES 36 0.0018
758 ULCER 29 0.0018
759 INTERSTITIAL LUNG DISEASE 88 0.0018
760 BLOOD ALKALINE PHOSPHATASE INCREASED 45 0.0018
761 UPPER LIMB FRACTURE 36 0.0018
762 EAR PAIN 35 0.0018
763 HEPATITIS 46 0.0018
764 INCONTINENCE 19 0.0018
765 ABDOMINAL PAIN UPPER 369 0.0018
766 ENCEPHALOPATHY 44 0.0018
767 JOINT RANGE OF MOTION DECREASED 24 0.0018
768 APHASIA 54 0.0018
769 SKIN DISCOLOURATION 82 0.0018
770 DYSSTASIA 52 0.0018
771 BLOOD PRESSURE DECREASED 118 0.0018
772 HAEMATOCHEZIA 98 0.0018
773 RASH MACULAR 62 0.0018
774 MITRAL VALVE INCOMPETENCE 20 0.0018
775 IMPAIRED HEALING 58 0.0018
776 PROCEDURAL PAIN 49 0.0018
777 LETHARGY 101 0.0018
778 SCAB 20 0.0018
779 CARDIOGENIC SHOCK 25 0.0017
780 MUSCULAR WEAKNESS 197 0.0017
781 PRESYNCOPE 42 0.0017
782 AGEUSIA 43 0.0017
783 METABOLIC ACIDOSIS 55 0.0017
784 SPINAL PAIN 20 0.0017
785 SHOCK 39 0.0017
786 COGNITIVE DISORDER 79 0.0017
787 NASOPHARYNGITIS 311 0.0017
788 SPEECH DISORDER 88 0.0017
789 DYSPHONIA 98 0.0017
790 HEART RATE INCREASED 166 0.0017
791 MEMORY IMPAIRMENT 229 0.0017
792 LOWER LIMB FRACTURE 32 0.0017
793 DIZZINESS 827 0.0017
794 HEMIPARESIS 28 0.0017
795 RASH PRURITIC 89 0.0016
796 ROTATOR CUFF SYNDROME 21 0.0016
797 GLOMERULAR FILTRATION RATE DECREASED 20 0.0016
798 DISCOMFORT 99 0.0016
799 HAIR COLOUR CHANGES 20 0.0016
800 TYPE 2 DIABETES MELLITUS 54 0.0016
801 ARTHRITIS 126 0.0016
802 FACE OEDEMA 27 0.0016
803 CHOKING 31 0.0016
804 LIVER INJURY 39 0.0016
805 SWELLING 148 0.0016
806 MYALGIA 267 0.0016
807 PROSTATE CANCER 125 0.0016
808 MYOCARDIAL INFARCTION 270 0.0015
809 HIATUS HERNIA 20 0.0015
810 BALANCE DISORDER 133 0.0015
811 LUNG NEOPLASM MALIGNANT 63 0.0015
812 GAIT DISTURBANCE 288 0.0015
813 RASH 654 0.0015
814 CARPAL TUNNEL SYNDROME 21 0.0015
815 ARTHRALGIA 621 0.0015
816 CHEST PAIN 276 0.0015
817 DISORIENTATION 59 0.0015
818 BURSITIS 18 0.0015
819 ADRENAL INSUFFICIENCY 18 0.0015
820 DEPRESSED MOOD 77 0.0015
821 FEMUR FRACTURE 45 0.0015
822 PROSTATIC SPECIFIC ANTIGEN INCREASED 20 0.0015
823 BEDRIDDEN 19 0.0014
824 FEELING ABNORMAL 345 0.0014
825 TOXICITY TO VARIOUS AGENTS 242 0.0014
826 DERMATITIS ALLERGIC 18 0.0014
827 BRADYCARDIA 75 0.0014
828 HEPATOCELLULAR INJURY 20 0.0014
829 STEVENS-JOHNSON SYNDROME 31 0.0014
830 SEIZURE 161 0.0014
831 PAIN 845 0.0014
832 ANKLE FRACTURE 21 0.0014
833 PULMONARY FIBROSIS 26 0.0014
834 CIRCULATORY COLLAPSE 23 0.0013
835 HAIR TEXTURE ABNORMAL 18 0.0013
836 PULMONARY HYPERTENSION 28 0.0013
837 PAIN IN EXTREMITY 396 0.0013
838 PANCREATITIS 70 0.0013
839 DEMENTIA 37 0.0013
840 IMPAIRED GASTRIC EMPTYING 18 0.0013
841 RECTAL HAEMORRHAGE 56 0.0013
842 GLAUCOMA 25 0.0013
843 PANCREATITIS ACUTE 29 0.0013
844 DEPRESSED LEVEL OF CONSCIOUSNESS 51 0.0013
845 NECK PAIN 72 0.0013
846 DIABETES MELLITUS 98 0.0013
847 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 33 0.0013
848 MUSCLE SPASMS 235 0.0013
849 MENTAL IMPAIRMENT 31 0.0013
850 MUSCULOSKELETAL DISCOMFORT 22 0.0013
851 BLOOD GLUCOSE ABNORMAL 23 0.0012
852 ABDOMINAL PAIN LOWER 31 0.0012
853 ALOPECIA 240 0.0012
854 DRUG INEFFECTIVE 1606 0.0012
855 TREMOR 197 0.0012
856 TREATMENT FAILURE 98 0.0012
857 URINARY INCONTINENCE 35 0.0012
858 BLOOD PRESSURE FLUCTUATION 28 0.0012
859 MUSCULOSKELETAL PAIN 60 0.0011
860 DRY EYE 57 0.0011
861 HEART RATE DECREASED 40 0.0011
862 BLISTER 63 0.0011
863 PRURITUS 429 0.0011
864 PALPITATIONS 130 0.0011
865 FRACTURE 21 0.0011
866 VERTIGO 67 0.0011
867 OSTEOARTHRITIS 46 0.0011
868 BLINDNESS 44 0.0011
869 DIPLOPIA 28 0.0011
870 JOINT INJURY 23 0.0011
871 HEAD DISCOMFORT 19 0.0011
872 LIMB DISCOMFORT 33 0.0011
873 HYPOTHYROIDISM 34 0.0011
874 CARDIOVASCULAR DISORDER 27 0.0011
875 INTENTIONAL PRODUCT MISUSE 93 0.0011
876 DISABILITY 21 0.0011
877 PRODUCT PRESCRIBING ISSUE 23 0.0011
878 FOOT FRACTURE 20 0.0011
879 HEADACHE 659 0.0011
880 ECZEMA 55 0.0010
881 UNRESPONSIVE TO STIMULI 27 0.0010
882 CHEST DISCOMFORT 107 0.0010
883 ARTHROPATHY 58 0.0010
884 PRODUCT ADMINISTRATION ERROR 21 0.0010
885 TOOTH DISORDER 23 0.0010
886 INSOMNIA 275 0.0010
887 LIVER FUNCTION TEST ABNORMAL 30 0.0010
888 ADVERSE EVENT 95 0.0010
889 SNEEZING 23 0.0010
890 HYPERHIDROSIS 132 0.0010
891 VISUAL IMPAIRMENT 126 0.0010
892 THERAPY INTERRUPTED 72 0.0010
893 ERYTHEMA 206 0.0010
894 DRY MOUTH 81 0.0010
895 SOMNOLENCE 201 0.0010
896 GAMMA-GLUTAMYLTRANSFERASE INCREASED 22 0.0010
897 THERAPEUTIC RESPONSE DECREASED 60 0.0010
898 EATING DISORDER 21 0.0010
899 RASH PAPULAR 22 0.0010
900 FREQUENT BOWEL MOVEMENTS 26 0.0010
901 HYPOAESTHESIA 144 0.0010
902 SLEEP DISORDER 67 0.0009
903 RESPIRATORY ARREST 26 0.0009
904 EYE DISORDER 31 0.0009
905 WEIGHT INCREASED 211 0.0009
906 JOINT SWELLING 113 0.0009
907 DYSARTHRIA 35 0.0009
908 DEPRESSION 211 0.0009
909 RASH ERYTHEMATOUS 44 0.0009
910 RHABDOMYOLYSIS 38 0.0009
911 COMA 43 0.0009
912 IRRITABLE BOWEL SYNDROME 19 0.0009
913 PAIN IN JAW 25 0.0009
914 AMNESIA 57 0.0009
915 INTERVERTEBRAL DISC PROTRUSION 19 0.0009
916 NASAL CONGESTION 51 0.0009
917 THERAPY CESSATION 44 0.0009
918 CHRONIC KIDNEY DISEASE 64 0.0008
919 INTERNATIONAL NORMALISED RATIO INCREASED 24 0.0008
920 CONDITION AGGRAVATED 253 0.0008
921 SWELLING FACE 53 0.0008
922 HALLUCINATION 61 0.0008
923 RENAL INJURY 24 0.0008
924 JOINT STIFFNESS 21 0.0008
925 INCORRECT DOSE ADMINISTERED 182 0.0008
926 ANAPHYLACTIC REACTION 44 0.0008
927 BLOOD PRESSURE INCREASED 121 0.0008
928 LACTIC ACIDOSIS 25 0.0008
929 SKIN EXFOLIATION 65 0.0008
930 VISION BLURRED 105 0.0008
931 DRY SKIN 102 0.0008
932 THERAPEUTIC RESPONSE UNEXPECTED 34 0.0008
933 FEELING HOT 46 0.0007
934 ROAD TRAFFIC ACCIDENT 31 0.0007
935 TINNITUS 34 0.0007
936 MENTAL DISORDER 32 0.0007
937 ANXIETY 208 0.0007
938 DYSGEUSIA 54 0.0007
939 INFLUENZA LIKE ILLNESS 59 0.0007
940 BLOOD GLUCOSE INCREASED 133 0.0007
941 THROAT TIGHTNESS 19 0.0007
942 PANCREATIC CARCINOMA 20 0.0007
943 BLOOD GLUCOSE DECREASED 33 0.0007
944 BLADDER CANCER 40 0.0007
945 PARAESTHESIA 106 0.0007
946 HYPERSENSITIVITY 125 0.0007
947 BLOOD CREATINE PHOSPHOKINASE INCREASED 19 0.0007
948 INJURY 45 0.0006
949 EPILEPSY 19 0.0006
950 URTICARIA 104 0.0006
951 AGGRESSION 31 0.0006
952 WHEEZING 36 0.0006
953 BURNING SENSATION 42 0.0006
954 CONTRAINDICATED PRODUCT ADMINISTERED 18 0.0006
955 MUSCULOSKELETAL STIFFNESS 52 0.0006
956 EYE SWELLING 22 0.0006
957 BLOOD CHOLESTEROL INCREASED 26 0.0006
958 RESTLESSNESS 20 0.0005
959 UNDERDOSE 39 0.0005
960 AGITATION 38 0.0005
961 HYPOGLYCAEMIA 25 0.0005
962 ILL-DEFINED DISORDER 31 0.0005
963 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 89 0.0005
964 THROAT IRRITATION 21 0.0005
965 DISTURBANCE IN ATTENTION 25 0.0005
966 OSTEOPOROSIS 19 0.0005
967 NERVOUSNESS 23 0.0004
968 MIGRAINE 42 0.0004
969 TREATMENT NONCOMPLIANCE 24 0.0004
970 OCULAR HYPERAEMIA 20 0.0004
971 IRRITABILITY 25 0.0004
972 EYE PAIN 23 0.0004
973 FLUSHING 41 0.0004
974 NO ADVERSE EVENT 65 0.0004
975 MEDICATION ERROR 19 0.0003
976 DRUG EFFECT DECREASED 18 0.0003
977 PRODUCT STORAGE ERROR 29 0.0003
978 ACNE 25 0.0003
979 EMOTIONAL DISTRESS 38 0.0003
980 ASTHMA 35 0.0003
981 HOT FLUSH 23 0.0003
982 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 57 0.0003
983 BREAST CANCER 23 0.0002
984 DRUG DOSE OMISSION 37 0.0002
985 PRODUCT DOSE OMISSION ISSUE 60 0.0002
986 OVERDOSE 38 0.0002
987 INJECTION SITE PAIN 21 0.0001